跳至主要内容
临床试验/NCT04227197
NCT04227197已完成不适用

A Randomized, Controlled Trial of an Online Health Tool About Down Syndrome

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 281 人开始时间: 2017年10月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
281
试验地点
1
主要终点
Number of Participants With Indicated Evaluations That Were Completed or Recommended by the PCP

研究概览

简要总结

The investigators conducted a national two-arm, randomized controlled trial of caregivers of individuals with DS to assess the efficacy of DSC2U in assuring adherence to evidence-based guidelines. The research plan was approved by the Partners Human Research Committee.

详细描述

Background: The overwhelming majority of people with Down syndrome do not have access to specialty clinics, a disparity resulting in delayed or missed diagnoses and significant untreated co-morbidities. To meet this critical gap in needs, the investigators created "Down Syndrome Clinic to You" (DSC2U), a novel, web-based tool created for caregivers of individuals with Down syndrome, which generates personalized recommendations for the caregiver and the patient's primary care provider (PCP).

Methods: In a national, randomized controlled trial of 230 caregivers who had children or dependents with Down syndrome without access to a Down syndrome specialist, 117 were randomized to receive DSC2U and 113 to receive usual-care. The primary outcome was adherence to five health evaluations indicated by national guidelines for Down syndrome: celiac screen, sleep study, thyroid test, audiogram, and ophthalmology evaluation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
1 Year 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Potential eligible participants were directed to the study website (www.dsc2u.org) for the eligibility screening questionnaire in English and Spanish and online consent. After selecting a language preference (English or Spanish), in addition to questions about the child's or dependent's biological sex, race and ethnicity, the eligibility screening questions included:
  • •Do you have a child or dependent with DS?
  • •Is your child or dependent 1 year or older?
  • •When is your child's next annual well visit ("PCP visit")?
  • •Does your child or dependent currently receive care at a DS specialty clinic? (If the child or dependent was actively followed in a DS specialty clinic, even one out of state. For example, a family from Arizona who travels to Texas each year for their child to be seen in a DS specialty clinic would be ineligible)
  • •Inclusion Criteria:
  • •If you have a child or dependent with Down syndrome (DS)
  • •If your child or dependent is 1 year or older
  • •If your child or dependent is does not receive care at a DS specialty clinic

排除标准

  • •If your child or dependent does receive care at a DS specialty clinic
  • •If your child or dependent is under 1 year old
  • •If your child or dependent has a PCP that is already involved in the study
  • •DS occurs naturally and proportionally in all races and ethnicities, so the study's population estimates were proportional to the racial/ethnic distribution of the U.S. population, as reported in the 2010 U.S. Census. To achieve commensurate representation in the study, the investigators applied a quota system in offering enrollment using the race and ethnicity of the individual with DS (not the caregiver).
  • •The investigators' plan was to enroll participants such that there were: no more than 144 white individuals with DS, no fewer than 25 Hispanic or Latino/Latina individuals with DS, and no fewer than 20 black individuals with DS. The team also planned to enroll no more than 120 individuals with DS of one sex.

研究组 & 干预措施

Intervention Group

Experimental

The participants randomized to the intervention group completed the DSC2U questionnaire, and received online access to a personalized Caregiver Checklist and PCP plan. Caregivers were encouraged to share and discuss the PCP plan at their next wellness visit with the PCPs.

干预措施: Down Syndrome Clinic to You (DSC2U) (Other)

Control Group

No Intervention

The participants randomized to the control group, received usual care for 7 months, after their scheduled PCP appointment. They did not receive DSC2U during these 7 months, but did receive the online, personalized health assessment tool (DSC2U) at the end of the 7 months, after the primary and secondary outcomes were measured.

结局指标

主要结局

Number of Participants With Indicated Evaluations That Were Completed or Recommended by the PCP

时间窗: 7 months after the participant's scheduled PCP visit

Adherence to the five health evaluations indicated by national guidelines for Down syndrome. The five health evaluations included: celiac screen, sleep study, thyroid test, audiogram, and ophthalmology evaluation.

次要结局

  • Quality of Life Outcomes for Person With Down Syndrome: 7-month Follow-up(7-month follow-up survey)
  • Questionnaire: Caregiver Experience With the Intervention(2 weeks and 7 months after their scheduled PCP visit and with the intervention)
  • Quality of Life Outcomes for Person With Down Syndrome: 2-week Follow-up(Change from baseline at the 2-week follow-up time point)
  • PCP Experience With the Intervention (Down Syndrome Clinic to You)(2 weeks after the scheduled PCP visit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brian G Skotko

Director, Down Syndrome Program

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验